Emergent BioSolutions Logo

Emergent BioSolutions

🇺🇸
EBS
US29089Q1058

Emergent BioSolutions is a global life sciences company headquartered in the U.S. It specializes in developing and manufacturing medical countermeasures against infectious diseases, opioid overdoses, and biological threats through innovative pharmaceutical solutions.

Next Quarterly Earnings

Wednesday, November 11, 2026
CW 46
After-Hours
In 76 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 14, 2026

Stock Price

Frequently asked questions

When will Emergent BioSolutions report its next quarterly earnings?

Emergent BioSolutions is scheduled to report its next quarterly earnings on 11/11/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Emergent BioSolutions last report quarterly earnings?

Emergent BioSolutions last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 0.60 USD.

How often has Emergent BioSolutions beaten expectations?

Emergent BioSolutions has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).

How do I add the Emergent BioSolutions earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.41
Actual:
Q2 2026
Beat
Estimate:$0.11
Actual:$0.60
Difference:+$0.49
Price reaction (1 day):-29.6 %
Price reaction (7 days):-39.7 %
Q1 2026
Beat
Estimate:-$0.25
Actual:$0.21
Difference:+$0.46
Price reaction (1 day):+2.9 %
Price reaction (7 days):+10.9 %
Q3 2025
Missed
Estimate:$0.11
Actual:-$0.43
Difference:-$0.54
Q2 2025
Beat
Estimate:-$0.12
Actual:$1.06
Difference:+$1.18
Q1 2025
Beat
Estimate:-$0.49
Actual:$0.16
Difference:+$0.65

Earnings statistics

Estimates vs. results

4/5
Quarters above estimates
80%
Beat rate
+90.7%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Emergent BioSolutions
Ticker Symbol
EBS
ISIN
US29089Q1058
Country
🇺🇸
USA
Sector